InvestorsHub Logo
Followers 22
Posts 1379
Boards Moderated 0
Alias Born 03/31/2017

Re: None

Thursday, 01/14/2021 11:07:16 AM

Thursday, January 14, 2021 11:07:16 AM

Post# of 403568

Fast track didn't help Absssi much... It's a nice carrot but everything still has to play out....




It is NOT that FAST TRACK..."didn't help Absssi" it is that the licensee has not taken advantage of it!!!

For IPIX... more than a carrot...its an huge additional asset for Brilacidin/IPIX to move forward with and RECOGNITION OF ITS PROBABLE SUCCESS in attaining FDA approval! (and FDA knows it...that is why it is given!)


Innovation Pharmaceuticals’ Brilacidin for the Treatment of COVID-19 Receives FDA Fast Track Designation

FDA Grants IND Approval for Phase 2 Clinical Trial of Innovation Pharmaceuticals - Brilacidin for Treating
COVID-19

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News